Impact of CYP2C19 Metabolizer Status on Patients with ACS Treated with Prasugrel Versus Clopidogrel

TRILOGY ACS Investigators

Research output: Contribution to journalArticlepeer-review

33 Scopus citations

Fingerprint

Dive into the research topics of 'Impact of CYP2C19 Metabolizer Status on Patients with ACS Treated with Prasugrel Versus Clopidogrel'. Together they form a unique fingerprint.

Medicine & Life Sciences